Introduction
============

Screening for colorectal cancer, one of the most common causes of cancer-related mortality [@JR025-1], has been shown to decrease colorectal cancer mortality rates. In colorectal cancer screening, histopathology is the reference standard for the classification of polyps detected during colonoscopy. There are several reasons why it is recommended that endoscopists predict the histopathology of the colonic lesions detected. First, accurate recognition of early carcinomas is essential in the decisions related to follow-up treatment. For some early carcinomas, endoscopic resection is feasible while others should be primarily referred for surgery, avoiding a complication risk of polypectomy. Moreover, every suspicious lesion should be marked with a tattoo to secure future localization [@JR025-1] [@JR025-2] [@JR025-3] [@JR025-4]. Second, colonoscopy would become more efficient and cost-effective if the endoscopist was able to differentiate lesions based on the endoscopic image only, and if only a rather limited number of polyps had to be sent for pathological examination. Discarding lesions without histopathologic evaluation would reduce costs and time required for final diagnosis and determining a surveillance interval. However, this would only acceptable if lesions of interest were correctly identified during colonoscopy and if cancers were not missed. The landmark "DISCARD-trial" and several subsequent studies demonstrated that expert endoscopists reach a negative predictive value of 90 % or more for diminutive adenomas and this was regarded as an appropriate threshold for discarding the use of pathological assessment in diagnosing these lesions [@JR025-2] [@JR025-5]. However, these studies were conducted in an expert setting with systematic use of advanced imaging techniques. A Dutch study in a non-academic setting showed optical diagnosis of colorectal lesions with narrow band imaging (NBI) is suboptimal [@JR025-6]. Third, in routine colonoscopy, resected polyps are obtained for histopathologic assessment. In some cases, however, the endoscopist is unable to obtain all polyps for histopathologic assessment; therefore, surveillance intervals must be determined by the predicted histopathology.

In the routine daily setting of the third round of a FIT-based screening pilot program, we retrospectively evaluated the ability of endoscopists to predict the histopathology of colorectal lesions with conventional white light colonoscopy. In addition, we compared the accuracy of diagnosis of different sized lesions: diminutive, small, and large, and compared the accuracy of the diagnoses of gastroenterology consultants and fellows.

Methods
=======

Data were collected during colonoscopies performed in the third round of a pilot program of FIT-based screening for CRC in Amsterdam, the Netherlands. The methods and results for the separate screening rounds have been reported in detail elsewhere [@JR025-2] [@JR025-4]. FITs and the reagents required for laboratory assessment were provided by Eiken Chemical Company, LTD, Japan.

Population and design
=====================

Asymptomatic individuals between 50 and 75 years were invited to participate in FIT-based screening. Institutionalized people were excluded from participation. Participants who had tested negative in the first or second round of assessments were invited to participate again. More information about the design and procedures for invitations have been described elsewhere [@JR025-2] [@JR025-6].

Colonoscopy and pathology
=========================

All participants with a positive FIT-screening test were invited for a consultation at one of the two screening centers between July and December 2011. During this consultation, the implications of the positive test were described to the participant. If no contraindications were present, a colonoscopy was advised and the procedure was discussed with the participant.

All colonoscopies were performed using Olympus (160 and 180 series) endoscopes without standard use of NBI, However, NBI or chromoendoscopy were used upon the discretion of the endoscopist. Twelve endoscopists were gastrointestinal tract consultants and eleven were fellows.

Histopathologists were blinded for the outcome of the endoscopic assessment. Data on location, size, macroscopic aspect (endoscopic diagnosis; eg., hyperplastic polyp, adenoma, carcinoma, or other), morphology, procedure for removal, and endoscopic assessment of radical resection of each consecutive patient were recorded for all lesions detected during colonoscopy. Lesions were evaluated according to the Vienna criteria by an experienced gastrointestinal pathologist, who was blinded to the endoscopic assessment [@JR025-2] [@JR025-3] [@JR025-4] [@JR025-7]. Lesions were classified as an adenocarcinoma, an adenoma (tubular, tubulovillous, villous), a hyperplastic polyp, a sessile serrated adenoma, a traditional serrated adenoma, or as miscellaneous. Dysplasia was defined as either low‐grade or high‐grade.

Statistics
==========

Sensitivity and specificity estimates were calculated by comparing the evaluation by the endoscopist with the histopathology findings, which was used as the clinical reference standard. Lesions were categorized as hyperplastic, adenoma, carcinoma or other (eg., pseudo polyps, normal polyp-like mucosa, inverted diverticulosis). We statistically assessed adenomas and carcinomas versus other lesions. Lesions were excluded if no histology was available or if the lesion was a sessile serrated adenoma/polyp or traditional serrated adenoma because these are difficult to recognize and were not included in the endoscopist's options on the Clinical Research Form ([Fig. 1](#FI025-1){ref-type="fig"}). We did not collect data on reproducibility.

![ Patient and polyp inclusion criteria.](10-1055-s-0034-1377173-i025ei1){#FI025-1}

We analyzed separately diminutive (\< 6 mm), small (6 -- 9 mm), and large (≥ 10 mm) lesions and diagnoses by the fellows and consultants. Chi square test statistics were used to compare the proportions in subgroups. Statistical analyses were performed with SPSS 19.0.

Results
=======

In the third FIT-screening round, 318 patients with a positive FIT screen underwent colonoscopy; their mean age was 62.3 (SD 6.8); 176 (55 %) were men. Mean number of polyps per patient was 2.6 (SD 1.75). The colonoscopies were performed by 23 endoscopists in two hospitals; eight endoscopists performed 260 colonoscopies (74 %). Two-hundred and four screening participants (64 %) had at least one lesion detected during colonoscopy. In all, 683 lesions were detected; 564 (83 %) of these were included in the analyses ([Fig. 1](#FI025-1){ref-type="fig"}).

All lesions
-----------

The pathologists classified the 564 lesions as: 141 hyperplastic polyps, 349 adenomas, 16 carcinomas, and 58 other lesions ([Fig. 1](#FI025-1){ref-type="fig"} and [Table 1](#TB025-1){ref-type="table"}). [Table 2](#TB025-2){ref-type="table"} shows the sensitivity, specificity, and positive and negative predictive valued (PPV and NPV) for polyp assessment for diagnosis of adenoma and carcinoma.

###### Characteristics of included lesions.

                                                 All(564)    Hyperplastic (N = 141)   Adenoma(N = 349)   Carcinoma(N = 16)
  ---------------------------------------------- ----------- ------------------------ ------------------ -------------------
  **Size**   \< 6 mm 6 -- 9 mm  ≥ 1 cm Missing   353108949   1172031                  19483684           0016
  **Location**  Distal Proximal Missing          30720552    104289                   16114543           106

###### Sensitivity and specificity for adenomas and carcinomas.

                         All lesions (N = 564)                           PPV                   NPV                   
  ---------------------- ----------------------------------------------- --------------------- ------------- ------- ------
  **Endoscopist**        **Histopathology**                                                                          
                         **Adenomatous**                                 **Non-adenomatous**   **Total**             
  Adenomatous            307 (88 %)                                      110 (51 %)            417 (74 %)    74 %    26 %
  Non-adenomatous         42 (12 %)                                      105 (49 %)            147 (26 %)            
  Total                  349 (62 %)[\*](#FN025-2){ref-type="table-fn"}   215 (38 %)            564                   
  Sensitivity (95 %CI)   88 % (84 -- 91)                                                                             
  Specificity (95 %CI)   49 % (42 -- 55)                                                                             
                                                                                                                     
                         **Carcinoma**                                                                               
                         **Carcinoma**                                   **Non-carcinoma**     **Total**             
  Carcinoma              12 (75 %)                                         3 (0.5 %)            15 (2.7 %)   2.7 %   97 %
  Non-carcinoma           4 (25 %)                                       545 (99 %)            549 (97 %)            
  Total                  16 (2.8 %)                                      548 (97 %)            564                   
  Sensitivity (95 %CI)   75 % (44 -- 89)                                                                             
  Specificity (95 %CI)   99 % (98 -- 100)                                                                            

62 % of all adenomatous lesions as assessed by the histopathologist.

For adenomas, endoscopic assessment was correct for 307 of 349 lesions (88 %). Of the 42 lesions that were incorrectly diagnosed by the endoscopist as an adenoma, histopathology revealed 40 (11 %) hyperplastic polyps and two cancers (0.6 %). The sensitivity of the endoscopist for adenomas was 88 % (95 %CI 84 -- 91) and specificity was 49 % (95 %CI 42 -- 55). [Fig. 2](#FI025-2){ref-type="fig"} shows a hyperplastic polyp that was assessed by the endoscopist as an adenoma.

![ Flat polyp (8 mm) in the transverse colon, which was, after submucosal lifting with normal saline, removed with snare polypectomy. Histopathology predicted a hyperplastic polyp, however, it was identified as a tubular adenoma with low-grade dysplasia.](10-1055-s-0034-1377173-i025ei2){#FI025-2}

Endoscopic diagnosis was correct in 12 of the 16 cancers (75 %). All four incorrectly diagnosed cancers were assessed by the endoscopist as adenoma and were 10 -- 15 mm in diameter. None of these carcinomas were marked with a tattoo.

We classified the cancers using the American Joint Committee on Cancer stages ([Table 3](#TB025-3){ref-type="table"}). Seven cancers were stage I and four of these were correctly identified as carcinomas by the endoscopist. All three incorrectly classified carcinomas were assessed as an adenoma. [Fig. 3](#FI025-3){ref-type="fig"} shows one of these lesions. Two of the misdiagnosed carcinomas were sessile lesions and one was pedunculated. Two carcinomas were classified as stage II and both were correctly identified by the endoscopist. Seven carcinomas were classified as stage III; six were correctly identified and one was assessed as a sessile adenoma. [Table 4](#TB025-4){ref-type="table"} and [Table 5](#TB025-5){ref-type="table"} show the sensitivity and specificity for fellows and consultants for diagnosis of adenomas and carcinomas, respectively. There were no significant differences in polyp assessment between the two groups of endoscopists.

###### Classification of Carcinomas (N = 16).

                                                                                       Endoscopist        
  ------------------------------------------------------------------------------------ ------------- ---- ----
  Stage ([\*](#FN025-3){ref-type="table-fn"})([\*\*](#FN025-4){ref-type="table-fn"})                      
   I                                                                                   3              4    7
   II                                                                                  0              2    2
   III                                                                                 1              6    7
  Total                                                                                4             12   16

All carcinomas were ≥ 10 mm.

TNM classification and staging, 7^th^ edition^9^

###### Sensitivity and specificity for adenomas for consultants and fellows.

                         Consultant (N = 297)    PPV                   NPV                 
  ---------------------- ----------------------- --------------------- ------------ ------ ------
  **Consultant**         **Histopathology**                                                
                         **Adenomatous**         **Non-adenomatous**   **Total**           
  Adenomatous            166 (88 %)               66 (61 %)            232 (78 %)   78 %   22 %
  Non-adenomatous         22 (12 %)               43 (39 %)             65 (22 %)          
  Total                  188 (63 %)              109 (37 %)            297                 
  Sensitivity (95 %CI)   89 % (83 -- 93)                                                   
  Specificity (95 %CI)   39 % (31 -- 50)                                                   
                                                                                           
                         **Fellows (N = 259)**                                             
  **Fellow**             **Histopathology**                                                
                         **Adenomatous**         **Non-adenomatous**   **Total**           
  Adenomatous            134 (86 %)               45 (43 %)            179 (69 %)   69 %   31 %
  Non-adenomatous         21 (14 %)               59 (57 %)             80 (31 %)          
  Total                  155 (60 %)              104 (40 %)            259                 
  Sensitivity (95 %CI)   86 % (80 -- 91)                                                   
  Specificity (95 %CI)   57 % (47 -- 66)                                                   

###### Sensitivity and specificity for carcinomas for consultants and fellows.

  ---------------------- -------------------------- ------------------- -------------
                         **Consultant (N = 297)**                       
  **Consultant**         **Histopathology**                             
                         **Carcinoma**              **Non-carcinoma**   **Total**
  Carcinoma                6 (67 %)                   0 (0.0 %)           6 (2.0 %)
  Non-carcinoma            3 (33 %)                 288 (100 %)         291 (98 %)
  Total                    9 (3.0 %)                288 (97 %)          297
  Sensitivity (95 %CI)    67 % (35 -- 91)                               
  Specificity (95 %CI)   100 % (98 -- 100)                              
                                                                        
                         **Fellows (N = 259)**                          
  **Consultant**         **Histopathology**                             
                         **Carcinoma**              **Non-carcinoma**   **Total**
  Carcinoma              4 (57 %)                     3 (1.1 %)           7 (2.7 %)
  Non-carcinoma          3 (43 %)                   249 (99 %)          252 (97 %)
  Total                  7 (2.7 %)                  252 (97 %)          259
  Sensitivity (95 %CI)   57 % (20 -- 88)                                
  Specificity (95 %CI)   99 % (96 -- 100)                               
  ---------------------- -------------------------- ------------------- -------------

![ Sessile polyp (10 mm) localized in the distal sigmoid, removed in toto with snare polypectomy after lifting with normal saline. Histopathology predicted an adenomatous polyp; no tattoo was placed; however, it was identified as an adenocarcinoma with submucosal invasion. Additional laparoscopic low anterior resection was performed. The resection specimen revealed no residual tumor, but one local positive lymph node. The colorectal carcinoma was classified as stage III.](10-1055-s-0034-1377173-i025ei3){#FI025-3}

Size
----

[Table 6](#TB025-6){ref-type="table"} and [Table 7](#TB025-7){ref-type="table"} show the endoscopic prediction subdivided for diminutive, small, and large lesions for adenomas and carcinomas, respectively. Of 564 lesions, 351 (62 %) were scored as diminutive, 108 (19 %) as small, and 95 (17 %) as large; in 10 (1.8 %) lesions the size was not recorded. All 16 carcinomas were 10 mm or larger. There were no significant differences in the endoscopist's accuracy of polyp assessment between diminutive, small, and large lesions.

###### Sensitivity and specificity for diminutive, smallv and large adenomas.

  ---------------------- ------------------------- --------------------- -------------
                         **\< 6 mm (N = 351)**                           
                         **Adenomatous**           **Non-adenomatous**   **Total**
  Adenomatous            156 (80 %)                 73 (46 %)            229 (65 %)
  Non-adenomatous         38 (20 %)                 84 (54 %)            122 (35 %)
  Total                  194 (55 %)                157 (45 %)            351
  Sensitivity (95 %CI)   80 % (74 -- 86)                                 
  Specificity (95 %CI)   54 %(45 -- 61)                                  
                                                                         
                         **6 -- 9 mm (N = 108)**                         
                         **Adenomatous**           **Non-adenomatous**   **Total**
  Adenomatous            82 (99 %)                 20 (80 %)             102 (94 %)
  Non-adenomatous         1 (1.0 %)                 5 (20 %)               6 (6.0 %)
  Total                  83 (77 %)                 25 (23 %)             108
  Sensitivity (95 %CI)   99 (93 -- 100)                                  
  Specificity (95 %CI)   20 (5.3 -- 37)                                  
                                                                         
                         **≥ 1 cm (N = 95)**                             
                         **Adenomatous**           **Non-adenomatous**   **Total**
  Adenomatous            65 (96 %)                 13 (50 %)             78 (81 %)
  Non-adenomatous         3 (4.0 %)                13 (50 %)             17 (19 %)
  Total                  68 (72 %)                 26 (27 %)             95
  Sensitivity (95 %CI)   96 (87 -- 99)                                   
  Specificity (95 %CI)   50 (30 -- 70)                                   
  ---------------------- ------------------------- --------------------- -------------

###### Sensitivity and specificity for diminutive, small, and large carcinomas.

  ---------------------- ------------------------- ------------------- -------------
                         **\< 6 mm (N = 351)**                         
                         **Carcinoma**             **Non-carcinoma**   **Total**
  Carcinoma              0 (0.0 %)                   0 (0.0 %)           0 (0.0 %)
  Non-carcinoma          0 (0.0 %)                 351 (100 %)         351 (100 %)
  Total                  0 (0.0 %)                 351 (100 %)         351
  Sensitivity (95 %CI)   NA                                            
  Specificity (95 %CI)   NA                                            
                                                                       
                         **6 -- 9 mm (N = 108)**                       
                         **Carcinoma**             **Non-carcinoma**   **Total**
  Carcinoma              0 (0.0 %)                   1 (0.9 %)         107 (99 %)
  Non-carcinoma          0 (0.0 %)                 107 (99 %)            1 (0.9 %)
  Total                  0 (0.0 %)                 108 (100 %)         108
  Sensitivity (95 %CI)   0 (0 -- 0)                                    
  Specificity (95 %CI)   99 (94 -- 100)                                
                                                                       
                         **≥ 1 cm (N = 95)**                           
                         **Carcinoma**             **Non-carcinoma**   **Total**
  Carcinoma              12 (75 %)                  2 (2.5 %)          14 (15 %)
  Non-carcinoma           4 (25 %)                 77 (97 %)           81 (85 %)
  Total                  16 (17 %)                 79 (83 %)           95
  Sensitivity (95 %CI)   75 (44 -- 91)                                 
  Specificity (95 %CI)   50 (30 -- 70)                                 
  ---------------------- ------------------------- ------------------- -------------

Negative predictive value for diminutive lesions
------------------------------------------------

Negative predictive value for diminutive adenomas was 69 % (60 -- 77). Because no diminutive carcinomas were detected and no polyps were classified as carcinomas, the NPV for diminutive carcinomas was not calculated.

Discussion
==========

Our study evaluated the accuracy of endoscopists in their assessment of polyps from colonic lesions detected during routine colonoscopy among FIT-positive participants in a third round of screening. Our study suggests endoscopic prediction of histopathology of polyps and early cancer is suboptimal in daily practice of a FIT-based screening program using routine white light colonoscopy.

Some limitations of our study should be discussed. It has been shown that training improves accuracy for correct prediction of histopathology [@JR025-1] [@JR025-5] [@JR025-8] [@JR025-9]. All endoscopists were experienced in performing routine colonoscopies, however, they did not receive any specific training for assessment of polyps from colorectal lesions. However, our intention was to evaluate polyp assessment of endoscopists in a routine, daily setting. In that setting, endoscopists used Olympus 160 and 180 endoscopes. They were allowed to use NBI or chromoendoscopy at their discretion, but this was not usually done. Literature demonstrates that advanced colonoscopic imaging methods like non-magnified/magnified NBI or chromoendoscopy improve accuracy of optical diagnosis [@JR025-10] [@JR025-11] [@JR025-12] [@JR025-13] [@JR025-14] Finally, we did not evaluate the level of confidence of the endoscopists in predicting polyp histopathology in diminutive lesions only, as was done previously in the DISCARD-study [@JR025-2] [@JR025-5] [@JR025-15].

To our knowledge this is the first study to report on endoscopic assessment of polyps during colonoscopies in a FIT-based screening setting. In early 2014, a nationwide FIT-based screening program was implemented in the Netherlands. This will increase the demand on colonoscopic capacity, making cost- and time-effectiveness more important. For routine assessment of basic quality measures in the screening program, an accreditation and auditing system for endoscopists and endoscopic units was established in the UK and is now established in the Netherlands [@JR025-1] [@JR025-6] [@OR025-16]. Contrary to the outcomes of the DISCARD trial [@JR025-2] [@JR025-4] [@JR025-15] [@JR025-17], which showed that histopathology could be omitted in a dedicated setting and with the use of NBI, our results show that consideration of histopathology in a setting of FIT-based screening and daily practice should not be omitted when using white light endoscopy only.

If endoscopists were to meet the PIVI-criteria of the American Society of Gastrointestinal Endoscopy, histopathologic assessment of diminutive and, perhaps, small polyps, could be omitted while leaving rectosigmoidal hyperplastic polyps in situ [@JR025-1] [@JR025-2] [@JR025-8]. However, the correct assessment of early carcinomas is important. These lesions are more prevalent in a FIT-positive population. The tailor-made decision to perform endoscopic resection or primary surgical treatment depends on correct endoscopic assessment of the lesion. Endoscopic resection of a lesion that appears to be invasive in the submucosa can lead to an unnecessary risk of bleeding, perforation, or tumor spread [@JR025-2] [@JR025-3] [@JR025-4] [@JR025-7]. Our study shows that these lesions are inadequately assessed in routine practice as only four (57 %) of seven early (T1) carcinomas were correctly identified by the endoscopists. Moreover, one stage III carcinoma was misdiagnosed. All incorrectly identified carcinomas were assessed as adenomas and endoscopically resected. In addition, the endoscopist did not place a tattoo to ensure accurate margins for the surgical resection were visible during surgery.

Remarkably, there was no significant difference in accuracy between fellows and consultants, indicating that experience in performing colonoscopies alone is not the key to accurate polyp assessment. Studies have shown that specific training in optical diagnosis increases diagnostic accuracy [@JR025-2] [@JR025-5] [@JR025-15]. It is possible that a training program would enable Dutch endoscopists to meet these criteria. However, for safe assessment and subsequent optimal treatment of carcinomas, optical diagnostic sensitivity must be high and in our study sensitivity for optical detection of carcinomas was disappointing at 75 %. The effect of a training program on the endoscopist's recognition of early cancers is not known and should be determined. In addition to improved training of endoscopists, the assessment of polyps could also be improved by upgrading endoscopic technology to high-definition processors, endoscopes, and video-screens. Routine use of image enhancement techniques like chromoendoscopy, NBI, flexible spectral imaging color enhancement, or iScan and standardized classifications like the NBI International Colorectal Endoscopic classification could also improve accuracy of polyp assessment [@JR025-18] [@JR025-19].

In conclusion, in a Dutch routine practice setting and screening without specific training or use of (digital) chromoendoscopy, endoscopic prediction of the histopathology of colonic lesions is inaccurate and one in four cancers is misdiagnosed as an adenoma. The literature reveals that a specific training program could increase the accuracy of polyp assessment by endoscopists. We find that a training program could help to increase accuracy in daily colonoscopic practice.

CRC

:   colorectal cancer

FIT

:   fecal immunochemical test

NBI

:   narrow band imaging

NPV

:   negative predictive value

PPV

:   positive predictive value
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